HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hisami Watanabe Selected Research

Hisami Watanabe Research Topics

Disease

9Neoplasms (Cancer)
09/2022 - 05/2002
7Infections
03/2023 - 07/2002
7Malaria
01/2017 - 12/2005
3Myositis Ossificans (Fibrodysplasia Ossificans Progressiva)
01/2021 - 01/2019
3Falciparum Malaria (Plasmodium falciparum Malaria)
01/2017 - 09/2005
3Hepatocellular Carcinoma (Hepatoma)
12/2007 - 01/2002
2COVID-19
09/2023 - 11/2022
2Human Influenza (Influenza)
03/2023 - 01/2022
2Parasitemia
05/2014 - 06/2006
2Granuloma
03/2007 - 03/2003
2Hepatitis
07/2004 - 07/2002
1Glioblastoma (Glioblastoma Multiforme)
09/2023
1Severe Acute Respiratory Syndrome
11/2022
1Fever (Fevers)
01/2022
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021
1Diffuse Intrinsic Pontine Glioma
01/2019
1Lymphoma (Lymphomas)
08/2014
1Primary Effusion Lymphoma
08/2014
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2012
1Neoplasm Metastasis (Metastasis)
06/2012
1Wounds and Injuries (Trauma)
06/2012
1Leukemia
03/2012
1Necrosis
08/2009
1Citrullinemia
12/2007
1Bacterial Infections (Bacterial Infection)
03/2007
1Inflammation (Inflammations)
03/2007
1Acute Liver Failure (Fulminant Hepatic Failure)
07/2005
1Autoimmune Diseases (Autoimmune Disease)
01/2005
1Colic (Abdominal Cramps)
11/2003
1Hypoxia (Hypoxemia)
08/2002
1Massive Hepatic Necrosis
05/2002

Drug/Important Bio-Agent (IBA)

6AutoantibodiesIBA
05/2014 - 07/2002
4Proteins (Proteins, Gene)FDA Link
11/2022 - 06/2003
3Messenger RNA (mRNA)IBA
09/2023 - 03/2003
3Activin Receptors (Activin Receptor)IBA
01/2021 - 01/2019
2Immunoglobulin G (IgG)IBA
09/2023 - 11/2022
2Oseltamivir (Tamiflu)FDA Link
03/2023 - 01/2022
2baloxavirIBA
03/2023 - 01/2022
2Lysine (L-Lysine)FDA Link
09/2022 - 05/2022
2DNA (Deoxyribonucleic Acid)IBA
05/2014 - 07/2002
2AntigensIBA
06/2012 - 08/2006
2Galactosylceramides (Galactocerebrosides)IBA
06/2012 - 08/2009
2Glucosylceramides (Glucocerebrosides)IBA
06/2012 - 08/2009
2Interleukin-17 (Interleukin 17)IBA
09/2008 - 03/2007
1Histones (Histone)IBA
09/2023
1Transcription Factors (Transcription Factor)IBA
09/2023
1Viral RNAIBA
03/2023
1Neuraminidase (Sialidase)IBA
03/2023
1laninamivirIBA
03/2023
1Zanamivir (Relenza)FDA Link
03/2023
1Anti-Idiotypic AntibodiesIBA
11/2022
1EnzymesIBA
11/2022
1AntibodiesIBA
11/2022
1ImmunosorbentsIBA
11/2022
1PyrazolesIBA
01/2021
1Cyclic PeptidesIBA
01/2021
16-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
01/2021
1pyrazoleIBA
05/2020
1LigandsIBA
05/2020
1dipinacoline glutamateIBA
01/2019
1Interleukin-10 (Interleukin 10)IBA
01/2017
1Caspase 9IBA
08/2014
1FullerenesIBA
08/2014
1ZincIBA
06/2013
1Dendrimers (Dendrons)IBA
01/2013
1Poly(amidoamine)IBA
01/2013
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
08/2012
1InterferonsIBA
06/2012
1Proto-Oncogene Proteins c-pim-1 (Proto Oncogene Proteins c pim 1)IBA
03/2012
1Mefloquine (Lariam)FDA LinkGeneric
07/2011
1SugarsIBA
08/2009
1A-factor (Streptomyces)IBA
08/2009
1CeramidesIBA
08/2009
1Reactive Oxygen Species (Oxygen Radicals)IBA
08/2009
1citrinIBA
12/2007
1Small Interfering RNA (siRNA)IBA
12/2007
1Histocompatibility Antigens Class IIBA
12/2007
1Interleukin-23 (Interleukin 23)IBA
03/2007
1CytokinesIBA
03/2007
1ErythropoietinFDA Link
12/2005
1Sulfadoxine (Sulformethoxine)FDA Link
09/2005
1Pyrimethamine (Daraprim)FDA Link
09/2005
1pyrimethamine drug combination fanasil (Fansidar)FDA Link
09/2005
1Chemotactic FactorsIBA
07/2004
1Concanavalin AIBA
07/2004
1Cell Adhesion MoleculesIBA
08/2002
1deoxyhemoglobinIBA
08/2002
1IsofluraneFDA LinkGeneric
08/2002
1Oxyhemoglobins (Oxyhemoglobin)IBA
08/2002
1Glycyrrhizic Acid (Glycyrrhizin)IBA
07/2002
1stronger neominophagen CIBA
07/2002
1Immunoglobulin M (IgM)IBA
07/2002
1Transaminases (Aminotransferases)IBA
05/2002
1Fas Ligand Protein (Fas Ligand)IBA
05/2002

Therapy/Procedure

2Home Nursing (Nursing, Home)
09/2023 - 11/2022
2Liver Transplantation
07/2005 - 11/2003
1Aftercare (After-Treatment)
03/2023
1Therapeutics
08/2012
1Protein-Restricted Diet (Diet, Protein Restricted)
06/2006
1Catheters
11/2003